No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BLFS250117P17500
- 0.00
- 0.000.00%
15min DelayClose Jan 8 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover0.00%IV36.80%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma15.82Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $31
Maxim Group Initiates BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $34
Northland Capital Markets Maintains Outperform on BioLife Solns, Raises Price Target to $31
BioLife Solns Analyst Ratings
Investors Bid BioLife Solutions (NASDAQ:BLFS) up US$53m Despite Increasing Losses YoY, Taking Five-year CAGR to 11%
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $34